The AI boom has been generating hype and headlines for several years now, and deservedly so. It’s transforming the way ...

Sarepta stock surged after the pharma company said it would lay off a third of its workforce and add a black-box warning to ...

J&J's stock price is down from its 2022 peak, but it's performed better than you might think by simply looking at its chart.

A long-time Palantir Technologies bull, Tom Nash, is doubling down on the stock following its 434% rally over the past 12 months.

SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the ...

Stocks were taken on a wild ride Wednesday as a White House official indicated to CNBC that Trump was moving closer to firing ...

Major U.S. equities indexes were little changed at midday Wednesday after a report on wholesale inflation showed a surprising ...

Johnson & Johnson shows steady growth in Q2, driven by medtech and oncology, yet talc litigation overshadows. Click for my ...

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) is one of the best oversold NASDAQ stocks to buy now. On July 14, William Blair ...

Health care stocks have outperformed so far in 2025 despite uncertainty surrounding the Donald Trump administration's policies. Health care stocks can often be a solid defensive play in an ...

Kairos Pharma reported strong safety results from a Phase 2 trial of ENV-105 in mCRPC, with no serious toxicities seen in the ...

Buying stocks that are trading at cheap valuations can set you up for some big gains later on. And it can minimize the risk ...